Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer

Overview of attention for article published in BMC Medical Genomics, July 2012

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 2,092 followers.

Genomic signatures for predicting survival & adjuvant chemotherapy benefit in patients with non-small-cell lung cancer. http://t.co/RwqmwIf3

New publication from ChipDX. Two gene signatures for predicting prognosis and chemotherapy benefit for patients... http://t.co/PRuaMsgc

Genomic signatures for predicting survival and adjuvant chemotherapy: Improved methods are needed for predicting... http://t.co/jMpQO82x

Genomic signatures for predicting survival and adjuvant chemotherapy: Improved methods are needed for predicting... http://t.co/KjY6vkLE

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.